跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SITAGLIPTINA/METFORMINA SANDOZ FARMACEUTICA 50MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SITAGLIPTINA/METFORMINA SANDOZ FARMACEUTICA 50MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
SITAGLIPTINA/METFORMINA SANDOZ FARMACEUTICA 50MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Sandoz Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 31, 2022
Approval ID
7d4f9ab0c8f23bc5
Company
Sandoz Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
7d4f9ab0c8f23bc5
Drug Cima Aemps Name
SITAGLIPTINA/METFORMINA SANDOZ FARMACEUTICA 50MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
86734
Holder Company Name
Sandoz Farmaceutica S.A.
Marketing Company Name
Sandoz Farmaceutica S.A.
Authorization Date
2022-03-31
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
50 mg/1.000 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Sandoz Farmaceutica S.A.
Active Ingredients
SITAGLIPTINA HIDROCLORURO MONOHIDRATO
56,7 mg
METFORMINA HIDROCLORURO
1.000 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 31, 2022
Approval ID
7d4f9ab0c8f23bc5
Type
Standard
Back to CIMA-AEMPS Approvals